MSLE ▲ +5.5% - Satellos Bioscience Inc. $MSLE - Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development 24-SEP-2026 07:00 AM ET